Madrigal Pharmaceuticals
MDGL
#2088
Rank
S$11.36 B
Marketcap
S$489.04
Share price
-4.45%
Change (1 day)
-31.66%
Change (1 year)

EPS for Madrigal Pharmaceuticals (MDGL)

EPS in 2026 (TTM): S-$7.62

According to Madrigal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S-$7.62. In 2025 the company made an earnings per share (EPS) of S-$13.79 an increase over its 2024 EPS that were of S-$28.52.

EPS history for Madrigal Pharmaceuticals from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$7.62-44.73%
2025S-$13.79-51.65%
2024S-$28.52
2022S-$22.2317.93%
2021S-$18.8511.61%
2020S-$16.89140.18%
2019S-$7.03146.61%
2018S-$2.85-12.99%
2017S-$3.28-91.03%
2016S-$36.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
S-$0.25-96.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S-$1.23-83.93%๐Ÿ‡บ๐Ÿ‡ธ USA